Top Markets
Coin of the day
Polaryx Therapeutics, Inc. Common Stock Polaryx Therapeutics, Inc. Common Stock

Polaryx Therapeutics, Inc. Common Stock

PLYX
Classement en actions #21586
Polaryx Therapeutics, Inc. functions as a biotechnology firm dedicated to... Polaryx Therapeutics, Inc. functions as a biotechnology firm dedicated to advancing small-molecule therapies for lysosomal storage and neurodegenerative conditions. Its developmental pipeline includes a trio of promising candidates: PLX-100, which combines PLX-200 with an ancillary supplement, targeting late infantile neuronal ceroid lipofuscinosis (LINCL) and related forms of NCL. PLX-200, a repurposed compound already utilized to address various diseases in both adult and pediatric populations. And PLX-300, derived from an edible plant, which works by activating PPARa to enhance the production of transcription factor EB. The company, established in 2014, maintains its base of operations in Paramus, New Jersey.
Prix de l'action
$2.10
Dernière synchronisation: 2026-08-21
Capitalisation boursière
$104.43M
Changement (1 jour)
-2.10%
Changement (1 an)
-
Pays
US
Échange Polaryx Therapeutics, Inc. Common Stock (PLYX)

Catégorie

Historique des divisions d’actions pour Polaryx Therapeutics, Inc. Common Stock (PLYX)
L’action Polaryx Therapeutics, Inc. Common Stock (symbole : PLYX) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 23, 2026.
Une action PLYX achetée avant le Aug 23, 2026 équivaudrait aujourd’hui à 0 actions PLYX.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH